Buy or sell PrognomiQ stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

PrognomiQ Stock

PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.

About PrognomiQ Stock

PrognomiQ is a biotechnology firm that develops test products for the early detection and treatment of cancer and other complex diseases through the power of multi-omics data.

Funding History

September 2020$55.0M
March 2022$46.0M

Management

Interim CFO

David Siewers

Chief Executive Officer, President & Founder

Philip Ma

Co-Founder & Chairman

Omid Farokhzad

Board of Director

Tomer Berkovitz

Distinguished Scientist

John E. Blume

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo